Literature DB >> 3549328

Cyclosporin A does not affect the in vitro induction of antigen-specific delayed-type hypersensitivity-mediating T cells.

B Shidani, I Motta, P Truffa-Bachi.   

Abstract

The effect of cyclosporin A (CsA) on the in vitro induction of sheep red blood cell (SRBC)-specific T cells mediating the delayed-type hypersensitivity (DTH) reaction was studied. CsA (1 microgram/ml) addition to the culture medium totally inhibits the in vitro anti-SRBC humoral response but does not interfere with the generation of anti-SRBC DTH-mediating T (TDTH) cells. The induction of TDTH requires the presence of antigen and their expression is mediated selectively by the antigen used in the culture. The TDTH cells generated are Lyt-1+,2- and their induction occurs with a similar efficiency in CsA-treated and untreated cultures: the frequency of the TDTH cells increases by a factor of 10 to 20 during the 6-day incubation period. Lyt-2+ suppressor cells are also generated in CsA-treated or untreated cultures. Our results suggest that a small fraction of T cells can be driven into the proliferative pathway by antigen even in presence of CsA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549328     DOI: 10.1002/eji.1830170222

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.

Authors:  L M Webster; A W Thomson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.